Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2010-08-02

Clinical Trial Update: Persistence of Rabies Antibody 1-5 Years After the Post-exposure Prophylaxis With Vero Cell Antirabies Vaccine and Antibody Response to a Single Booster Dose [Phase 4]

View source ↗

Summary

This Phase 4 trial update assesses how long rabies antibodies persist for 1-5 years after post-exposure prophylaxis with a Vero cell-derived rabies vaccine and …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Vero cell-derived rabies vaccine (rabies vaccine, Vero cell-derived)

Snippet

Sponsor: Peking University People's Hospital | Conditions: Rabies | Phase 4 | Status: UNKNOWN